drug

olpasiran

Status: Investigational
Code: AMG 890
Trials: 1 registered trial in coverage

Relationships

Targets Lipoprotein(a)

Developed by Amgen

Timeline

No published stories yet.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.